betaine has been researched along with Brain Swelling in 3 studies
glycine betaine : The amino acid betaine derived from glycine.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The clinical features of untreated CBS deficiency include myopia, ectopia lentis, mental retardation, skeletal anomalies resembling Marfan syndrome, and thromboembolic events." | 1.42 | Successive MRI Findings of Reversible Cerebral White Matter Lesions in a Patient with Cystathionine β-Synthase Deficiency. ( Asano, T; Fukao, T; Kawamoto, M; Kawamoto, N; Kimura, T; Matsui, E; Sasai, H; Shimozawa, N; Yamamoto, T, 2015) |
| "We conclude that the cerebral edema was most likely precipitated by the betaine therapy, although the exact mechanism is uncertain." | 1.31 | Progressive cerebral edema associated with high methionine levels and betaine therapy in a patient with cystathionine beta-synthase (CBS) deficiency. ( Allen, RH; Braverman, N; Geraghty, MT; Kashani, AH; Mudd, SH; Okoh, J; Pomper, M; Stabler, SP; Tangerman, A; Wagner, C; Yaghmai, R, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sasai, H | 1 |
| Shimozawa, N | 1 |
| Asano, T | 1 |
| Kawamoto, N | 1 |
| Yamamoto, T | 1 |
| Kimura, T | 1 |
| Kawamoto, M | 1 |
| Matsui, E | 1 |
| Fukao, T | 1 |
| Devlin, AM | 1 |
| Hajipour, L | 1 |
| Gholkar, A | 1 |
| Fernandes, H | 1 |
| Ramesh, V | 1 |
| Morris, AA | 1 |
| Yaghmai, R | 1 |
| Kashani, AH | 1 |
| Geraghty, MT | 1 |
| Okoh, J | 1 |
| Pomper, M | 1 |
| Tangerman, A | 1 |
| Wagner, C | 1 |
| Stabler, SP | 1 |
| Allen, RH | 1 |
| Mudd, SH | 1 |
| Braverman, N | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Efficacy of Betaine for Reduction of Urine Oxalate in Patients With Type 1 Primary Hyperoxaluria[NCT00283387] | Phase 2 | 15 participants (Actual) | Interventional | 2007-02-28 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
"The patients were randomly assigned oral betaine or placebo for 2 months, followed by a 2 month washout. Each patient then received the alternate study medication for 2 months.~Urinary Oxalate Excretion was measured by oxalate oxidase. Two 24 hour urine collections were obtained at baseline, and during the eighth week of each study period." (NCT00283387)
Timeframe: baseline, 2 months, 6 months
| Intervention | umol/mg (Mean) |
|---|---|
| Betaine | 1.43 |
| Placebo | 1.04 |
3 other studies available for betaine and Brain Swelling
| Article | Year |
|---|---|
Successive MRI Findings of Reversible Cerebral White Matter Lesions in a Patient with Cystathionine β-Synthase Deficiency.
Topics: Betaine; Brain; Brain Edema; Cell Membrane; Diet, Protein-Restricted; Diffusion Magnetic Resonance I | 2015 |
Cerebral edema associated with betaine treatment in classical homocystinuria.
Topics: Betaine; Brain Edema; Child, Preschool; Craniotomy; Cystathionine beta-Synthase; Decompression, Surg | 2004 |
Progressive cerebral edema associated with high methionine levels and betaine therapy in a patient with cystathionine beta-synthase (CBS) deficiency.
Topics: Betaine; Brain Edema; Child; Child, Preschool; Female; Homocystinuria; Humans; Infant; Infant, Newbo | 2002 |